电子健康档案中药物安全评估的处方监控系统:范围审查。

IF 3.3 3区 医学 Q2 MEDICAL INFORMATICS
Camilo Scherkl, Theresa Dierkes, Michael Metzner, David Czock, Hanna M Seidling, Walter E Haefeli, Andreas D Meid
{"title":"电子健康档案中药物安全评估的处方监控系统:范围审查。","authors":"Camilo Scherkl, Theresa Dierkes, Michael Metzner, David Czock, Hanna M Seidling, Walter E Haefeli, Andreas D Meid","doi":"10.1186/s12911-025-03096-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Medical care can fail for various reasons: diseases can remain undetected and their severity misjudged, therapies can be incorrectly dosed or ineffective, and therapies can trigger new conditions or adverse drug reactions (ADR). To manage the complexity of changing patient circumstances, data-driven techniques play an increasingly important role in monitoring patient safety and treatment success. Therefore, clinical prediction models need to consider longitudinal factors (\"Prescribing Monitoring\") to ensure clinically meaningful results and avoid misclassification in the dynamic health situation of the individual patient.</p><p><strong>Methods: </strong>We have conducted a scoping review (OSF registration: https://doi.org/10.17605/OSF.IO/P93TZ ) on prediction models for ADR to collect potential use cases for Prescribing Monitoring. This review identified 2435 relevant studies in English that were published in MEDLINE or EMBASE. Two reviewers screened the records for inclusion, with a third reviewer making the final decision in the event of discrepancies. In order to derive recommendations on the way towards a Prescribing Monitoring system, the following elements were extracted and interpreted: the prediction models used, selection of candidate predictors, use of longitudinal factors, and model performance.</p><p><strong>Results: </strong>A total of 56 studies were included after the screening process. We identified the main areas of current research in ADR prediction, all covering clinically important outcomes. We identified Prescribing Monitoring use cases based on their potential to (i) make individual predictions considering specific patient characteristics, (ii) make longitudinal predictions in a near time frame, and (iii) make dynamic predictions by updating predictions with previous risk predictions and newly available data. As a further aside, we use hyperkalaemia as an example to discuss the framework for developing Prescribing Monitoring in an electronic health record (EHR).</p><p><strong>Conclusion: </strong>This scoping review provides an overview of the use of time-varying effects and longitudinal variables in current prediction model research. For application to clinical cases, prediction models should be developed, validated and implemented on this basis, so that time-dependent information can enable continuous monitoring of individual patients.</p>","PeriodicalId":9340,"journal":{"name":"BMC Medical Informatics and Decision Making","volume":"25 1","pages":"244"},"PeriodicalIF":3.3000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12224581/pdf/","citationCount":"0","resultStr":"{\"title\":\"Towards a prescribing monitoring system for medication safety evaluation within electronic health records: a scoping review.\",\"authors\":\"Camilo Scherkl, Theresa Dierkes, Michael Metzner, David Czock, Hanna M Seidling, Walter E Haefeli, Andreas D Meid\",\"doi\":\"10.1186/s12911-025-03096-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Medical care can fail for various reasons: diseases can remain undetected and their severity misjudged, therapies can be incorrectly dosed or ineffective, and therapies can trigger new conditions or adverse drug reactions (ADR). To manage the complexity of changing patient circumstances, data-driven techniques play an increasingly important role in monitoring patient safety and treatment success. Therefore, clinical prediction models need to consider longitudinal factors (\\\"Prescribing Monitoring\\\") to ensure clinically meaningful results and avoid misclassification in the dynamic health situation of the individual patient.</p><p><strong>Methods: </strong>We have conducted a scoping review (OSF registration: https://doi.org/10.17605/OSF.IO/P93TZ ) on prediction models for ADR to collect potential use cases for Prescribing Monitoring. This review identified 2435 relevant studies in English that were published in MEDLINE or EMBASE. Two reviewers screened the records for inclusion, with a third reviewer making the final decision in the event of discrepancies. In order to derive recommendations on the way towards a Prescribing Monitoring system, the following elements were extracted and interpreted: the prediction models used, selection of candidate predictors, use of longitudinal factors, and model performance.</p><p><strong>Results: </strong>A total of 56 studies were included after the screening process. We identified the main areas of current research in ADR prediction, all covering clinically important outcomes. We identified Prescribing Monitoring use cases based on their potential to (i) make individual predictions considering specific patient characteristics, (ii) make longitudinal predictions in a near time frame, and (iii) make dynamic predictions by updating predictions with previous risk predictions and newly available data. As a further aside, we use hyperkalaemia as an example to discuss the framework for developing Prescribing Monitoring in an electronic health record (EHR).</p><p><strong>Conclusion: </strong>This scoping review provides an overview of the use of time-varying effects and longitudinal variables in current prediction model research. For application to clinical cases, prediction models should be developed, validated and implemented on this basis, so that time-dependent information can enable continuous monitoring of individual patients.</p>\",\"PeriodicalId\":9340,\"journal\":{\"name\":\"BMC Medical Informatics and Decision Making\",\"volume\":\"25 1\",\"pages\":\"244\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2025-07-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12224581/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMC Medical Informatics and Decision Making\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s12911-025-03096-3\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICAL INFORMATICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Medical Informatics and Decision Making","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12911-025-03096-3","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICAL INFORMATICS","Score":null,"Total":0}
引用次数: 0

摘要

背景:医疗保健可能因各种原因而失败:疾病可能未被发现,其严重程度可能被误判,治疗可能剂量不正确或无效,治疗可能引发新的疾病或药物不良反应(ADR)。为了管理不断变化的患者情况的复杂性,数据驱动技术在监测患者安全和治疗成功方面发挥着越来越重要的作用。因此,临床预测模型需要考虑纵向因素(“处方监测”),以确保临床有意义的结果,并避免在患者个体动态健康状况下的错误分类。方法:我们对ADR预测模型进行了范围审查(OSF注册:https://doi.org/10.17605/OSF.IO/P93TZ),以收集处方监测的潜在用例。本综述确定了2435篇发表在MEDLINE或EMBASE上的相关英文研究。两名审稿人对记录进行筛选以纳入,如果存在差异,第三名审稿人将做出最终决定。为了得出关于处方监测系统的建议,提取并解释了以下要素:使用的预测模型、候选预测因子的选择、纵向因素的使用和模型性能。结果:筛选后共纳入56项研究。我们确定了当前ADR预测研究的主要领域,所有这些领域都涵盖了重要的临床结果。我们根据处方监测用例的潜力(i)根据特定患者特征进行个体预测,(ii)在近时间框架内进行纵向预测,以及(iii)通过使用先前的风险预测和最新可用数据更新预测来进行动态预测。此外,我们以高钾血症为例,讨论在电子健康记录(EHR)中开发处方监测的框架。结论:本文综述了时变效应和纵向变量在当前预测模型研究中的应用。为了应用于临床病例,应该在此基础上开发、验证和实施预测模型,使随时间变化的信息能够实现对个体患者的连续监测。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Towards a prescribing monitoring system for medication safety evaluation within electronic health records: a scoping review.

Background: Medical care can fail for various reasons: diseases can remain undetected and their severity misjudged, therapies can be incorrectly dosed or ineffective, and therapies can trigger new conditions or adverse drug reactions (ADR). To manage the complexity of changing patient circumstances, data-driven techniques play an increasingly important role in monitoring patient safety and treatment success. Therefore, clinical prediction models need to consider longitudinal factors ("Prescribing Monitoring") to ensure clinically meaningful results and avoid misclassification in the dynamic health situation of the individual patient.

Methods: We have conducted a scoping review (OSF registration: https://doi.org/10.17605/OSF.IO/P93TZ ) on prediction models for ADR to collect potential use cases for Prescribing Monitoring. This review identified 2435 relevant studies in English that were published in MEDLINE or EMBASE. Two reviewers screened the records for inclusion, with a third reviewer making the final decision in the event of discrepancies. In order to derive recommendations on the way towards a Prescribing Monitoring system, the following elements were extracted and interpreted: the prediction models used, selection of candidate predictors, use of longitudinal factors, and model performance.

Results: A total of 56 studies were included after the screening process. We identified the main areas of current research in ADR prediction, all covering clinically important outcomes. We identified Prescribing Monitoring use cases based on their potential to (i) make individual predictions considering specific patient characteristics, (ii) make longitudinal predictions in a near time frame, and (iii) make dynamic predictions by updating predictions with previous risk predictions and newly available data. As a further aside, we use hyperkalaemia as an example to discuss the framework for developing Prescribing Monitoring in an electronic health record (EHR).

Conclusion: This scoping review provides an overview of the use of time-varying effects and longitudinal variables in current prediction model research. For application to clinical cases, prediction models should be developed, validated and implemented on this basis, so that time-dependent information can enable continuous monitoring of individual patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
7.20
自引率
5.70%
发文量
297
审稿时长
1 months
期刊介绍: BMC Medical Informatics and Decision Making is an open access journal publishing original peer-reviewed research articles in relation to the design, development, implementation, use, and evaluation of health information technologies and decision-making for human health.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信